Skip to main content
. 2023 Sep 1;14:1222044. doi: 10.3389/fphar.2023.1222044

TABLE 3.

No. (%) of patients fulfilling criterion at peak creatinine level during polymyxin B treatment.

IV group (n = 31) IH group (n = 32) IV + IH group (n = 33) p-Value
Normal 12(38.7) 24(75.0) 20(60.6) 0.025
Risk 8(25.8) 3(9.4) 3(9.2)
Injury 7(22.6) 4(12.5) 5(15.1)
Failure 4(12.9) 1(3.1) 5(15.1)